Clinical Trial Update: A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab in combination with axitinib for advanced renal cell carcinoma, including clear cell histology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Axitinib (Axitinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN